CAS 1561178-17-3
:5-Bromo-7-[5-deoxy-5-[[3-[[[[4-(1,1-dimethylethyl)phenyl]amino]carbonyl]amino]propyl](1-methylethyl)amino]-β-D-ribofuranosyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Description:
5-Bromo-7-[5-deoxy-5-[[3-[[[[4-(1,1-dimethylethyl)phenyl]amino]carbonyl]amino]propyl](1-methylethyl)amino]-β-D-ribofuranosyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine, with CAS number 1561178-17-3, is a complex organic compound characterized by its intricate molecular structure, which includes a pyrrolo[2,3-d]pyrimidine core. This compound features multiple functional groups, including bromine, amine, and carbonyl groups, contributing to its potential biological activity. The presence of a ribofuranosyl moiety suggests that it may interact with biological systems, possibly influencing nucleic acid metabolism or enzyme activity. Its bulky substituents, such as the tert-butyl group, may affect its solubility and permeability, which are critical for pharmacological applications. The compound's synthesis and characterization would typically involve advanced organic chemistry techniques, and its stability, reactivity, and potential therapeutic uses would be of interest in medicinal chemistry research. Overall, this compound exemplifies the complexity often found in drug-like molecules, highlighting the interplay between structure and biological function.
Formula:C28H40BrN7O4
InChI:InChI=1S/C28H40BrN7O4/c1-16(2)35(12-6-11-31-27(39)34-18-9-7-17(8-10-18)28(3,4)5)14-20-22(37)23(38)26(40-20)36-13-19(29)21-24(30)32-15-33-25(21)36/h7-10,13,15-16,20,22-23,26,37-38H,6,11-12,14H2,1-5H3,(H2,30,32,33)(H2,31,34,39)/t20-,22-,23-,26-/m1/s1
InChI key:InChIKey=IQCKJUKAQJINMK-HUBRGWSESA-N
SMILES:O[C@H]1[C@H](N2C=3C(C(Br)=C2)=C(N)N=CN3)O[C@H](CN(CCCNC(NC4=CC=C(C(C)(C)C)C=C4)=O)C(C)C)[C@H]1O
Synonyms:- 5-Bromo-7-[5-deoxy-5-[[3-[[[[4-(1,1-dimethylethyl)phenyl]amino]carbonyl]amino]propyl](1-methylethyl)amino]-β-D-ribofuranosyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
- SGC 0946
- 7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 5-bromo-7-[5-deoxy-5-[[3-[[[[4-(1,1-dimethylethyl)phenyl]amino]carbonyl]amino]propyl](1-methylethyl)amino]-β-D-ribofuranosyl]-
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.
7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 5-bromo-7-[5-deoxy-5-[[3-[[[[4-(1,1-dimethylethyl)phenyl]amino]carbonyl]amino]propyl](1-methylethyl)amino]-β-D-ribofuranosyl]-
CAS:Formula:C28H40BrN7O4Purity:99%Color and Shape:SolidMolecular weight:618.5657SGC0946
CAS:<p>SGC0946 is a highly effective and specific DOT1L methyltransferase inhibitor (IC50: 0.3 nM); selectively kill mixed lineage leukemia cells.</p>Formula:C28H40BrN7O4Purity:98% - 99.82%Color and Shape:SolidMolecular weight:618.571-(3-((((2R,3S,4R,5R)-5-(4-Amino-5-bromo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(isopropyl)amino)propyl)-3-(4-(tert-butyl)phenyl)urea
CAS:Purity:99%Molecular weight:618.5770264SGC-0946
CAS:Controlled Product<p>Applications SGC0946 is a potent DOT1L methyltransferase inhbiitor used in the treatment of leukemia seen effectively in vitro.<br>References Yu, W. et al.: Nat. Commun., 3, 1288 (2012);<br></p>Formula:C28H40BrN7O4Color and Shape:NeatMolecular weight:618.57SGC0946
CAS:<p>SGC0946 is a methyltransferase inhibitor that inhibits the methylation of DNA by inhibiting the activity of DNA methyltransferase. It is being developed for use in regenerative medicine to inhibit transcriptional regulation and pluripotent cells. SGC0946 has been shown to be effective in inhibiting cell factor and human serum methyltransferase, which are responsible for the production of monocytes. SGC0946 also inhibits the production of cytokines, such as IL-1β, IL-6, and TNF-α, as well as chemokines such as RANTES and MCP-1. This drug also inhibits the growth of infectious diseases such as HIV-1 and HCV by disrupting dna methylation.</p>Formula:C28H40BrN7O4Purity:Min. 95%Molecular weight:618.57 g/mol





